Supplementary Figure Legends from Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment

Weifang Ling,Jimin Zhang,Zengrong Yuan,Guangwen Ren,Liying Zhang,Xiaodong Chen,Arnold B. Rabson,Arthur I. Roberts,Ying Wang,Yufang Shi

DOI: https://doi.org/10.1158/0008-5472.22400904

2023-01-01

Abstract:PDF file - 97KB

What problem does this paper attempt to address?

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Rajat Bhattacharya,Xiang-Cang Ye,Rui Wang,Xia Ling,Madonna McManus,Fan,Delphine Boulbes,Lee M. Ellis

DOI: https://doi.org/10.1158/0008-5472.22407995.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S12.
Supplementary Figures 1 - 7 from Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment

Weifang Ling,Jimin Zhang,Zengrong Yuan,Guangwen Ren,Liying Zhang,Xiaodong Chen,Arnold B. Rabson,Arthur I. Roberts,Ying Wang,Yufang Shi

DOI: https://doi.org/10.1158/0008-5472.22400901

2023-01-01

Abstract:PDF file - 794KB, Immunosuppressive effect of another constitutive IDO-expressing MSC clone MSC-IDOc2 (S1); Expression of iNOS or IDO in MSCs upon cytokine stimulation and their effect on lymphocyte proliferation (S2); Effect of iNOS-/- MSCs on proliferation of activated human peripheral blood mononuclear cells (S3); In Situ expression and location of human IDO in the tumor tissue (S4); Effect of IDO-expressing MSCs on the distribution of immune cell subpopulations in peripheral blood and tumor tissues (S5); Effect of IDO-expressing MSCs on the distribution of immune cell subpopulations in peripheral blood and tumor tissues (S6); Effect of IDO-expressing MSCs on the distribution of immune cell subpopulations in peripheral blood and tumor tissues (S7).
Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Xiaohui Fan,Randall J. Brezski,Hui Deng,Pooja Dhupkar,Yun Q. Shi,Anneliese Gonzalez,Songlin Zhang,Michael A. Rycyzyn,William R. Strohl,Robert E. Jordan,Ningyan Zhang,Zhiqiang An

DOI: https://doi.org/10.1158/1535-7163.22501711

2023-01-01

Abstract:Figure S1: IdeS expression in BT474 breast cancer cells Figure S2: Detection of MMPs in cancer cell lysates and culture supernatant Figure S3: scIgG-T was not in the SKBR-3 cell culture medium Figure S4: Detection of immune cells infiltration in mice by flow cytometry.
Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Wenqun Zhong,Zebin Xiao,Zhiyuan Qin,Jingbo Yang,Yi Wen,Ziyan Yu,Yumei Li,Neil C. Sheppard,Serge Y. Fuchs,Xiaowei Xu,Meenhard Herlyn,Carl H. June,Ellen Puré,Wei Guo

DOI: https://doi.org/10.1158/0008-5472.23907869

2023-01-01

Abstract:Supplementary Figures and Figure Legends
Supplementary Figure Legends 1-8 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Weibin Zou,Huilin Zheng,Tong-Chuan He,Jinjia Chang,Yang-Xin Fu,Weimin Fan

DOI: https://doi.org/10.1158/0008-5472.22392851.v1

2023-01-01

Abstract:PDF file - 164K
Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503690

2023-01-01

Abstract:PDF - 71K, Legends for Supplementary Figures 1 through 5.
Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis

Pengxu Qian,Zehua Zuo,Zhengsheng Wu,Xianyi Meng,Gaopeng Li,Zhengzhou Wu,Weijie Zhang,Sheng Tan,Vijay Pandey,Yandan Yao,Puyue Wang,Liqing Zhao,Jun Wang,Qiang Wu,Erwei Song,Peter E. Lobie,Zhinan Yin,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22391054

2023-01-01

Abstract:PDF file - 214K
Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Huafeng Wei,Hao Wang,Bing Lu,Bohua Li,Sheng Hou,Weizhu Qian,Kexing Fan,Jianxin Dai,Jian Zhao,Yajun Guo

DOI: https://doi.org/10.1158/0008-5472.22375065.v1

2023-01-01

Abstract:Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells
Supplemental Figure Legends from STING Promotes the Growth of Tumors Characterized by Low Antigenicity Via IDO Activation

Henrique Lemos,Eslam Mohamed,Lei Huang,Rong Ou,Gabriela Pacholczyk,Ali S. Arbab,David Munn,Andrew L. Mellor

DOI: https://doi.org/10.1158/0008-5472.22411824

2023-01-01

Abstract:Legends for Supplemental Figures S1-S3.
Supplementary Figure Legends from Mir-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Ting-Ting Yan,Lin-Lin Ren,Chao-Qin Shen,Zhen-Hua Wang,Ya-Nan Yu,Qian Liang,Jia-Yin Tang,Ying-Xuan Chen,Dan-Feng Sun,Witold Zgodzinski,Marek Majewski,Piotr Radwan,Ilona Kryczek,Ming Zhong,Jinxian Chen,Qiang Liu,Weiping Zou,Hao-Yan Chen,Jie Hong,Jing-Yuan Fang

DOI: https://doi.org/10.1158/0008-5472.22417241

2023-01-01

Abstract:This file contains figure legends corresponding to supplementary figures.
Supplemental Figure Legends from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition

Xiao Lin,Dae Joong Kim,Clayton L. Davis,James V. McCann,James M. Dunleavey,Alissa K. Vanderlinden,Nuo Xu,Samantha G. Pattenden,Stephen V. Frye,Xin Xu,Mark Onaitis,Elizabeth Monaghan-Benson,Keith Burridge,Andrew C. Dudley

DOI: https://doi.org/10.1158/0008-5472.22406702

2023-01-01

Abstract:Legends for Supplemental Figures S1-S7.
Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Jongchan Kim,Ashley N. Siverly,Dahu Chen,Min Wang,Yuan,Yumeng Wang,Hyemin Lee,Jinsong Zhang,William J. Muller,Han Liu,Boyi Gan,Xianbin Yang,Yeneng Sun,M. James You,Ma Li

DOI: https://doi.org/10.1158/0008-5472.22413063.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S11
Supplementary Figure 6 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Weibin Zou,Huilin Zheng,Tong-Chuan He,Jinjia Chang,Yang-Xin Fu,Weimin Fan

DOI: https://doi.org/10.1158/0008-5472.22392860.v1

2023-01-01

Abstract:PDF file - 1.3MB, Detection of I-Ad on MSC-L
Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407863

2023-01-01

Abstract:Legend for Supplementary Figures S1-S6.
Supplementary Figure 4 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Weibin Zou,Huilin Zheng,Tong-Chuan He,Jinjia Chang,Yang-Xin Fu,Weimin Fan

DOI: https://doi.org/10.1158/0008-5472.22392866.v1

2023-01-01

Abstract:PDF file - 1.8MB, MSC-L enhanced inflammation reaction in tumor tissues
Supplementary Figures Legends from Qa-1b Modulates Resistance to Anti–PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing

Xiao Zhang,Erich Sabio,Chirag Krishna,Xiaojing Ma,Jingming Wang,Hui Jiang,Jonathan J. Havel,Timothy A. Chan

DOI: https://doi.org/10.1158/1541-7786.22526916.v1

2023-01-01

Abstract:Supplemental Figure Legends 1-4
Supplementary Figure Legends from Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance Via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

Dalong Cao,Zihao Qi,Yangyang Pang,Haoran Li,Huyang Xie,Junlong Wu,Yongqiang Huang,Yao Zhu,Yijun Shen,Yiping Zhu,Bo Dai,Xin Hu,Dingwei Ye,Ziliang Wang

DOI: https://doi.org/10.1158/0008-5472.22418970

2023-01-01

Abstract:Supplementary Figure Legends
Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Li Liu,Xue Bai,Jian Wang,Xiaonan Tang,Dehua Wu,Shasha Du,Xiu-Ju Du,Yao-Wei Zhang,Hai‐Liang Zhu,Yuan Fang,Zhimou Guo,Qiandong Zeng,Xuejun Guo,Zhu Li,Zhong‐Yi Dong

DOI: https://doi.org/10.1158/1078-0432.22471917.v1

2023-01-01

Abstract:Supplementary figure legends
Supplemental Figure Legends from STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells

Heng Yang,Takahiro Yamazaki,Federico Pietrocola,Heng Zhou,Laurence Zitvogel,Yuting Ma,Guido Kroemer

DOI: https://doi.org/10.1158/0008-5472.22404671

2023-01-01

Abstract:Supplemental Figure Legends. Supplemental Figure Legends

Supplementary Figure Legends from Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figures 1 - 7 from Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Figure Legends 1-8 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplemental Figure Legends from STING Promotes the Growth of Tumors Characterized by Low Antigenicity Via IDO Activation

Supplementary Figure Legends from Mir-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Supplemental Figure Legends from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition

Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Supplementary Figure 6 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure 4 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figures Legends from Qa-1<sup>b</sup> Modulates Resistance to Anti–PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing

Supplementary Figure Legends from Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance Via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Supplemental Figure Legends from STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells

Supplementary Figure Legends from Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figures 1 - 7 from Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Figure Legends 1-8 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced &lt;i&gt;let-7g&lt;/i&gt; Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplemental Figure Legends from STING Promotes the Growth of Tumors Characterized by Low Antigenicity Via IDO Activation

Supplementary Figure Legends from Mir-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Supplemental Figure Legends from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition

Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Supplementary Figure 6 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure 4 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figures Legends from Qa-1&lt;sup&gt;b&lt;/sup&gt; Modulates Resistance to Anti–PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing

Supplementary Figure Legends from Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance Via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Supplemental Figure Legends from STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Supplementary Figures Legends from Qa-1<sup>b</sup> Modulates Resistance to Anti–PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing